FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Zelenskyy Holds Closed-Door Meeting with U.S. Senators, Urges Them to Turn Up the Heat on Trump

Breaking: Social Security Administration Cleans Up Records, Correctly Marks Millions as Deceased

Latest US-Ukraine tensions could determine these battleground races

French PM says far-left groups forged ‘insurrectionary plan’ against government

Italy sending hundreds of soldiers into Milan to quell days of violent riots

Bruce Blakeman hammers Dem Gov Hochul, Mamdani over subway safety during NYC campaign ride

Food delivery favorite forced to fork over millions after DOJ alleged discrimination against American workers

South Korea Kidnaps American Christian, Ex-Diplomat Who Dared to Criticize Nation’s President While on US Soil

US Chopper Spots Speed Boat Carrying 4,000 Pounds of Cocaine – Central American Authorities Seize It All

China ties suspected in sprawling California pot operations as GOP urges FBI probe

American who fled US after allegedly killing pregnant wife could return within days with murder charge dropped

Bush family royalty backs Democrat in battle to flip Texas blue

Dashcam video captures small plane crashing on San Jose highway, injuring three on board, including child

Vivek Ramaswamy lags behind Democrat Amy Acton in race to keep Ohio governor seat red

Alberta votes overwhelmingly to remain part of Canada in referendum

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”